【Ten Years of Rapid Development in Chemical Engineering Equipment】From 2030 to 2026, the large-scale low-temperature refrigeration systems developed by Zhongke Fuhai will help accelerate the development of the IP-SAFE project’s infrastructure for science and education

Thread Content

Let’s give praise and support to the achievements made in China’s chemical engineering technology and equipment; your participation in discussions is the greatest encouragement. **********************【Ten Years of Great Development in Chemical Engineering Equipment】Regular updates and summaries are available; feel free to join the discussions: https://bbs.hcbbs.com/thread-3576046-1-1.html *****************Recently, Zhongke Fuhai was invited to attend the event marking the completion of the on-site installation of the accelerator component for the world’s first accelerator-based platform for the development of medical isotope-targeted drugs (IP-SAFE), carried out by the Institute of Modern Physics of the Chinese Academy of Sciences (hereinafter referred to as the “Institute of Modern Physics”). Zhongke Fuhai provided a 4000W@4.5K large-scale cryogenic refrigeration system for this project, offering essential cryogenic cooling capacity for the accelerator equipment in the **IP-SAFE project for science and education infrastructure. The main accelerator unit of the IP-SAFE project, constructed by the Institute of Modern Physics, was successfully installed on-site in Lanzhou New Area. This marks the most important step forward in the construction of the world’s first industrial-scale production demonstration facility for alpha medical isotopes using a superconducting linear accelerator, laying a solid foundation for the complete realization of the IP-SAFE project. The IP-SAFE project, whose full name is “Accelerator-Based Platform for the Research and Development of Medical Isotope Drugs,” is one of the scientific and educational infrastructure initiatives under the **14th Five-Year Plan**. Leveraging the technical expertise and advantages of the Institute of Modern Physics in areas such as high-current superconducting linear accelerators, high-power targets, and isotope separation, this project aims to achieve large-scale production of medically important alpha isotopes that are in short supply worldwide – actinium-225 and radium-223 – in order to address China’s long-term reliance on imports for such high-end medical nuclear isotopes. Since its official launch on July 5, 2024, the project team has always adhered to the core principles of \"overcoming bottlenecks, ensuring quality, and improving efficiency.\" By working together with determination and perseverance, they managed to complete the on-site installation of the main components of the project accelerator device in a timely and orderly manner within less than one and a half years. The achievement of this interim result represents another significant step taken by the Institute of Modern Physics in pursuing the \"four orientations,\" facilitating the transformation of achievements from large-scale scientific facilities, and contributing to the health and well-being of the people. Once completed, this facility will significantly enhance the level of nuclear medicine diagnosis and treatment in our country, thereby injecting new momentum into the development of the biomedical industry there.